Journal
M S-MEDECINE SCIENCES
Volume 25, Issue 12, Pages 1159-1161Publisher
EDITIONS EDK
DOI: 10.1051/medsci/200925121159
Keywords
-
Categories
Ask authors/readers for more resources
The future of antibody fragments, made of a single immunoglobulin domain Monoclonal antibodies are now established as key therapeutics for a range of diseases including cancer and auto-immunity. However, despite important improvements, these molecules still face several serious limitations including production costs and tumor penetration. A new class of antibody fragments, made of a single immunoglobulin domain, is emerging as an exciting alternative, This review describes the outstanding properties and the first achievements of these domain antibodies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available